Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Oct;28(4):373-80.
doi: 10.1016/j.jpainsymman.2004.01.012.

Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer

Affiliations
Clinical Trial

Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer

Kristine A Donovan et al. J Pain Symptom Manage. 2004 Oct.

Abstract

Although much has been learned about the complication of fatigue during breast cancer treatment, the possibility that there are differences across treatment modalities in breast cancer patients' experience of fatigue has not yet been established. In this study, fatigue was assessed in 134 women receiving chemotherapy and radiotherapy or radiotherapy only for early stage breast cancer. Comparisons of fatigue during initial treatment indicated that women who received chemotherapy reported greater fatigue severity and disruptiveness than women receiving radiotherapy. Women not pre-treated with chemotherapy experienced increased fatigue over the course of radiotherapy. Results confirmed predictions that fatigue in women with early stage breast cancer differs as a function of the type of treatment and sequencing of treatment. Findings indicating increases in fatigue during radiotherapy only among women not pretreated with chemotherapy suggest a response shift, or a change in internal standards, in women's perceptions of fatigue as a function of prior chemotherapy treatment.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Fatigue severity among women treated with chemotherapy followed by radiotherapy.
Fig. 2
Fig. 2
Fatigue severity during radiotherapy for women pre-treated and not pre-treated with chemotherapy.
Fig. 3
Fig. 3
Fatigue disruptiveness during radiotherapy for women pre-treated and not pre-treated with chemotherapy.
Fig. 4
Fig. 4
Fatigue severity during initial type of therapy.
Fig. 5
Fig. 5
Fatigue disruptiveness during initial type of therapy.

References

    1. Winningham ML, Nail LM, Burke MB, et al. Fatigue and the cancer experience: The state of the knowledge. Oncol Nurs Forum. 1994;21:23–36. - PubMed
    1. Richardson A, Ream E. The experience of fatigue and other symptoms in patients receiving chemotherapy. Eur J Cancer Care. 1996;5(suppl 2):24–30. - PubMed
    1. Vogelzang NJ, Breitbart W, Cella D, et al. Patient, caregiver, and oncologist perceptions of cancer-related fatigue: Results of a tripart assessment survey. Semin Hematol. 1997;34(suppl 2):4–12. - PubMed
    1. Bower JE, Ganz PA, Desmond KA, et al. Fatigue in breast cancer survivors: Occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18:743–753. - PubMed
    1. Woo B, Dibble SL, Piper BF, et al. Differences in fatigue by treatment methods in women with breast cancer. Oncol Nurs Forum. 1998;25:915–920. - PubMed

Publication types

MeSH terms